216 related articles for article (PubMed ID: 34445557)
1. Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy Tests.
Kubiliute R; Jarmalaite S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445557
[TBL] [Abstract][Full Text] [Related]
2. Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring.
Crocetto F; Falcone A; Mirto BF; Sicignano E; Pagano G; Dinacci F; Varriale D; Machiella F; Giampaglia G; Calogero A; Varlese F; Balsamo R; Trama F; Sciarra A; Del Giudice F; Busetto GM; Ferro M; Lucarelli G; Lasorsa F; Imbimbo C; Barone B
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612677
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.
Yu X; Du Z; Zhu P; Liao B
Pharmacol Rep; 2024 Apr; 76(2):273-286. PubMed ID: 38388810
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma.
Cairns P
Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
[TBL] [Abstract][Full Text] [Related]
5. Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose.
Cinque A; Vago R; Trevisani F
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071652
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma.
Shi L; Wang M; Li H; You P
Cancer Manag Res; 2021; 13():7663-7675. PubMed ID: 34675663
[TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy.
Dybiec J; Frąk W; Kućmierz J; Tokarek J; Wojtasińska A; Młynarska E; Rysz J; Franczyk B
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254967
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers in renal cell carcinoma and their targeted therapies: a review.
Gupta S; Kanwar SS
Explor Target Antitumor Ther; 2023; 4(5):941-961. PubMed ID: 37970211
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.
Schiavoni V; Campagna R; Pozzi V; Cecati M; Milanese G; Sartini D; Salvolini E; Galosi AB; Emanuelli M
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370817
[TBL] [Abstract][Full Text] [Related]
10. Establishing a prognostic model based on five starvation-related long non-coding RNAs for clear cell renal cell carcinoma.
Yu Z; Chen G; Feng Z; Li Y; Yu H; Shi W; Gou X; Zhang C; Peng X
Aging (Albany NY); 2023 Jun; 15(14):6736-6748. PubMed ID: 37341994
[TBL] [Abstract][Full Text] [Related]
11. Role of the human solute carrier family 14 member 1 gene in hypoxia-induced renal cell carcinoma occurrence and its enlightenment to cancer nursing.
Shi J; Sha R; Yang X
BMC Mol Cell Biol; 2023 Mar; 24(1):10. PubMed ID: 36934247
[TBL] [Abstract][Full Text] [Related]
12. The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma.
Dibajnia P; Cardenas LM; Lalani AA
Hum Vaccin Immunother; 2023 Dec; 19(1):2178217. PubMed ID: 36775257
[TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model.
Qu G; Liu L; Yi L; Tang C; Yang G; Chen D; Xu Y
Front Genet; 2022; 13():1040421. PubMed ID: 36685882
[No Abstract] [Full Text] [Related]
14. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma.
Grammatikaki S; Katifelis H; Farooqi AA; Stravodimos K; Karamouzis MV; Souliotis K; Varvaras D; Gazouli M
In Vivo; 2023; 37(1):1-10. PubMed ID: 36593023
[TBL] [Abstract][Full Text] [Related]
15. Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses.
Žalimas A; Kubiliūtė R; Žukauskaitė K; Sabaliauskaitė R; Trakymas M; Letautienė S; Kaubrienė EM; Ušinskienė J; Ulys A; Jarmalaitė S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555747
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma.
Rosellini M; Marchetti A; Mollica V; Rizzo A; Santoni M; Massari F
Nat Rev Urol; 2023 Mar; 20(3):133-157. PubMed ID: 36414800
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Prevention of Renal Cell Carcinoma.
Makino T; Kadomoto S; Izumi K; Mizokami A
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011051
[TBL] [Abstract][Full Text] [Related]
18. LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma.
Sequeira JP; Constâncio V; Salta S; Lobo J; Barros-Silva D; Carvalho-Maia C; Rodrigues J; Braga I; Henrique R; Jerónimo C
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205607
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma.
Kubiliūtė R; Žukauskaitė K; Žalimas A; Ulys A; Sabaliauskaitė R; Bakavičius A; Želvys A; Jankevičius F; Jarmalaitė S
J Cancer Res Clin Oncol; 2022 Feb; 148(2):361-375. PubMed ID: 34689221
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
